The study identified four different types of pain among nursing home residents.

Published Date: 02 Mar 2023

Although it is recognized that pain is common among nursing home residents, little attention has been paid to how this pain changes over time. A new study from the Regenstrief Institute and the Indiana University School of Nursing...

Read Full News

Latest News

Bioterrorism and Disaster Medicine

This collection of news, notices, articles, and related links provide healthcare professionals with the latest information and resources related to caring for those affected by volatile world events such as terrorist attacks, war, and natural disasters.

Certain Eye Conditions Linked to Higher Odds of Loneliness

Nonproliferative diabetic retinopathy and blindness are associated with increased odds of loneliness, a study finds.

Next Gen DSM Gets a New Name — and a New Vision

The next diagnostic manual is expected to place greater emphasis on evidence-based science, biomarkers, and AI, with the goal of becoming a continuously updated ‘living’ document.

EMA Backs Broader Pediatric Use of Poxvirus Vaccine

EMA’s positive opinion would lower the approved age for Imvanex from 12 years to 2 years for smallpox, mpox, and vaccinia virus disease.

Mezigdomide Triplet Improves PFS in R/R Multiple Myeloma

A phase 3 trial evaluates the efficacy of mezigdomide plus carfilzomib and dexamethasone vs carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma.

Frailty in RA Is Linked to Disease Consequences, Not Age

Teaser: Frailty is more common in older adults with rheumatoid arthritis than in community peers and is associated with fatigue, comorbidities, and poorer physical function rather than age.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Latest News

This collection of news, notices, articles, and related links provide healthcare professionals with the latest information and resources related to caring for those affected by volatile world events such as terrorist attacks, war, and natural disasters.

Nonproliferative diabetic retinopathy and blindness are associated with increased odds of loneliness, a study finds.

The next diagnostic manual is expected to place greater emphasis on evidence-based science, biomarkers, and AI, with the goal of becoming a continuously updated ‘living’ document.

EMA’s positive opinion would lower the approved age for Imvanex from 12 years to 2 years for smallpox, mpox, and vaccinia virus disease.

A phase 3 trial evaluates the efficacy of mezigdomide plus carfilzomib and dexamethasone vs carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma.

Teaser: Frailty is more common in older adults with rheumatoid arthritis than in community peers and is associated with fatigue, comorbidities, and poorer physical function rather than age.

News All Time

The $5 Million Doctor

1 in 5 doctors say their family’s net worth has crossed $5 million.

Positive Topline Results for Novel LSD Formulation in MDD

A single dose of the LSD-based therapy DT120 produced rapid antidepressant effects that remained significant through 12 weeks in a pivotal phase 3 trial of major depressive disorder.

Pfizer Trial Backs Paxlovid Dose for High-Risk Children

A post-marketing trial finds the oral antiviral achieves effective blood concentrations in at-risk children aged 6 years or older with mild-to-moderate COVID.

Trofinetide Approved for Rett Syndrome After Reexamination

The EMA reverses its previous decision and grants marketing authorization to the world’s first drug specifically approved for treating the syndrome.

Carcinogen Concerns Trigger Review of Rifadin Syrup

Europe will be reviewing the tuberculosis medication following concerns raised by the Dutch medicines agency.

New Parkinson’s Drug Combines Immediate and Slow Release

The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease.

Is Creatine for Brain Health Worth a Try?

Research on creatine supplementation has moved from the gym to the brain lab, leading neurologist Heidi Moawad to review the data on creatine’s potential for improving cognitive health.

S1 Episode 2: Is Alcohol the Missing Piece in Your MASLD Workup?

Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera share practical tools to quantify intake, spot MetALD, and counsel patients effectively.

CGRP May Lower Weather-Related Migraine Risk

Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention.

Hyperbaric Oxygen Therapy Can Help in Refractory Colitis

Hyperbaric oxygen therapy is well tolerated in treatment-refractory ulcerative colitis and enhances clinical outcomes alongside improvement in bowel perfusion.

Ontario Docs to Screen Younger Patients for Colon Cancer

Ontario Health is poised to lower the colorectal cancer screening age to 45 years on July 1.

Primary Care Meets Artificial Intelligence

As AI continues to evolve, its integration into primary care is revolutionizing patient diagnosis, treatment, and management.

Canada Introduces Safe Social Media Act to Protect Children

Canada wants to make social media safer for children, but experts say key questions about how the law will actually work remain unanswered.

Heartburn Meds in Pregnancy Not Linked to Child GI Risk

Gastrointestinal reflux is common during pregnancy.

Do Involuntary Admissions Affect Clinicians’ Mental Health?

Researchers are examining how involuntary psychiatric admissions affect emergency clinicians, with findings expected to inform future support and training programs.

HSSIB Warns on Safety Gaps in Online Prescribing

NHS systems have failed to keep pace with the rapid growth of independent online prescribing, leaving clinicians without the information they need to prescribe safely, HSSIB warns.

Recommended News For You

improvements in the treatment of prostate cancer resistant to chemotherapy.

The risk of lung cancer recurrence is linked to hypoxemia brought on by sleep apnea.

The Effect of Common Steroids on Cancer Treatments.

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.

Study confirms link between breast density, higher breast cancer risk

Biocomputer From Human Neurons Plays Doom, Raises Ethics

Recommended Articles For You

Practical Directions in Oncology in Daily Practice 

Everything You Need to Know About the Latest Hyponatremia Algorithm  

Vaccines that can help prevent cancer 

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51% 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Housing aid linked to lower medical financial hardship among US renters with cancer

2.

Modified personalized cancer vaccine generates powerful immune response

3.

Cancer research in the US is world class. With the government pulling out, its future is uncertain

4.

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

5.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

1.

A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer

2.

Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions

3.

Contemporary Models in Oncology for Healthcare Excellence

4.

Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review

5.

Practical Applications in Hematology Across Clinical Settings

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

2.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot